Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 5
1962 4
1964 4
1966 2
1967 9
1968 2
1969 4
1970 2
1971 7
1972 3
1973 2
1974 1
1975 9
1977 1
1978 3
1979 4
1980 10
1981 10
1982 9
1983 13
1984 12
1985 22
1986 23
1987 13
1988 19
1989 25
1990 14
1991 14
1992 24
1993 26
1994 27
1995 37
1996 36
1997 43
1998 36
1999 47
2000 40
2001 42
2002 50
2003 50
2004 66
2005 63
2006 76
2007 87
2008 94
2009 68
2010 83
2011 129
2012 119
2013 131
2014 132
2015 105
2016 132
2017 161
2018 165
2019 166
2020 168
2021 173
2022 141
Text availability
Article attribute
Article type
Publication date

Search Results

2,699 results
Results by year
Filters applied: . Clear all
Page 1
Both microRNA-455-5p and -3p repress hypoxia-inducible factor-2α expression and coordinately regulate cartilage homeostasis.
Ito Y, Matsuzaki T, Ayabe F, Mokuda S, Kurimoto R, Matsushima T, Tabata Y, Inotsume M, Tsutsumi H, Liu L, Shinohara M, Tanaka Y, Nakamichi R, Nishida K, Lotz MK, Asahara H. Ito Y, et al. Among authors: nishida k. Nat Commun. 2021 Jul 6;12(1):4148. doi: 10.1038/s41467-021-24460-7. Nat Commun. 2021. PMID: 34230481 Free PMC article.
Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
Hieda O, Hiraoka T, Fujikado T, Ishiko S, Hasebe S, Torii H, Takahashi H, Nakamura Y, Sotozono C, Oshika T, Morimoto T, Nishida K, Nishikawa N, Song YS, Tokutake T, Nishi Y, Shigeno Y, Kurihara T, Negishi K, Tsubota K, Ono M, Nakai T, Tan D, Tanaka S, Kinoshita S; ATOM-J. Study Group. Hieda O, et al. Among authors: nishida k. Jpn J Ophthalmol. 2021 May;65(3):315-325. doi: 10.1007/s10384-021-00822-y. Epub 2021 Feb 14. Jpn J Ophthalmol. 2021. PMID: 33586090 Clinical Trial.
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.
Yabe D, Shiki K, Suzaki K, Meinicke T, Kotobuki Y, Nishida K, Clark D, Yasui A, Seino Y. Yabe D, et al. Among authors: nishida k. BMJ Open. 2021 Apr 7;11(4):e045844. doi: 10.1136/bmjopen-2020-045844. BMJ Open. 2021. PMID: 33827843 Free PMC article. Clinical Trial.
Generation of 3D lacrimal gland organoids from human pluripotent stem cells.
Hayashi R, Okubo T, Kudo Y, Ishikawa Y, Imaizumi T, Suzuki K, Shibata S, Katayama T, Park SJ, Young RD, Quantock AJ, Nishida K. Hayashi R, et al. Among authors: nishida k. Nature. 2022 May;605(7908):126-131. doi: 10.1038/s41586-022-04613-4. Epub 2022 Apr 20. Nature. 2022. PMID: 35444274
Recent Advances in Lipid-Based Drug Delivery.
Nishida K. Nishida K. Pharmaceutics. 2021 Jun 22;13(7):926. doi: 10.3390/pharmaceutics13070926. Pharmaceutics. 2021. PMID: 34206548 Free PMC article.
Trick of the Light Through the Cornea.
Koh S, Maeda N, Nishida K. Koh S, et al. Among authors: nishida k. Ophthalmology. 2021 Jun;128(6):836. doi: 10.1016/j.ophtha.2020.12.026. Ophthalmology. 2021. PMID: 34023051 Review. No abstract available.
2,699 results